LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Turn Therapeutics Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTTRX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TTRX COVERAGE

What’s moving Turn Therapeutics Inc. now

Current reporting with the operating signal separated from the noise.

01
Turn Therapeutics Inc. Rings the Nasdaq Stock Market Closing Bell

Turn Therapeutics Inc. Rings the Nasdaq Stock Market Closing Bell

Investors are testing whether Turn Therapeutics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TTRX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-31 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-28 · Period 2026-07-28SEC ↗8-KMaterial company eventFiled 2026-07-07 · Period 2026-07-07SEC ↗8-KMaterial company eventFiled 2026-06-03 · Period 2026-06-03SEC ↗4Official SEC filingFiled 2026-06-08 · Period 2026-06-04SEC ↗4Official SEC filingFiled 2026-06-08 · Period 2026-06-04SEC ↗
EARNINGS / QUARTERLY TRACKER

Turn Therapeutics Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.